Even Healthcare, an innovative Indian health technology startup, has successfully closed a $50 million Series B funding round, spearheaded by long-time investor Khosla Ventures. This substantial capital infusion, which also saw participation from Alpha Wave, propels the company’s valuation to $300 million, tripling its worth in just 18 months. The latest funding brings Even’s total capital raised to over $120 million, underscoring significant investor confidence in its ambitious mission to fundamentally reshape how hospitals in India operate, how they generate revenue, and how medical professionals are incentivized.
The core of Even’s disruptive strategy lies in challenging the prevailing fee-for-service model that dominates India’s vast healthcare landscape. This traditional structure often inadvertently encourages hospitals to prioritize revenue generation through additional tests, procedures, and extended patient stays, even when such interventions may not be medically necessary. Even Healthcare is determined to pivot this paradigm by focusing intently on patient care and optimal health outcomes, thereby dismantling the financial incentives that can drive up medical bills without corresponding improvements in health.
Addressing India’s Healthcare Conundrum: The Perverse Incentive Problem
India, with its rapidly growing population exceeding 1.4 billion, faces a multifaceted healthcare challenge. While the private sector plays a dominant role, accounting for a significant portion of healthcare expenditure, it is often criticized for its fragmentation, varying quality standards, and high out-of-pocket costs for patients. Reports from organizations like the National Health Accounts and various government surveys consistently highlight that out-of-pocket expenditure constitutes a substantial part of healthcare spending in India, pushing millions into poverty annually. This financial burden is exacerbated by a system where hospitals and doctors often derive greater revenue from more interventions, creating a potential conflict of interest between financial gain and patient well-being.
The traditional model in India, much like many parts of the world, compensates healthcare providers based on the volume of services rendered. This can lead to overtreatment, unnecessary diagnostics, and prolonged hospitalizations, all of which contribute to escalating healthcare costs for patients and insurers alike. Such practices erode patient trust and create an unsustainable economic model for the healthcare system. Even Healthcare’s founders identified this systemic flaw as a critical barrier to delivering high-quality, affordable care in India. Their vision is to build a system where financial success is intrinsically linked to positive patient outcomes and efficient care delivery, rather than the quantity of services performed.
Even Healthcare’s Transformative Model: From Partnership to Ownership
Initially, Even Healthcare embarked on its journey in 2021 by partnering with existing hospitals to provide care for its members. This approach, while offering a rapid entry into the market, soon revealed limitations. Mayank Banerjee, who co-founded Even with Matilde Giglio and Alessandro Ialongo, articulated in an interview that this reliance on partner institutions led to significant concerns. The startup observed instances where patients underwent tests or were recommended surgeries that Even’s clinical judgment deemed unnecessary. This misalignment with their core philosophy—to prioritize patient care over volume-driven revenue—prompted a strategic reassessment.
"We think patients are getting not only a bad experience, but insurers are getting a bad economic deal," Banerjee explained to TechCrunch. "And as a result, we decided to fix it by building our own hospitals." This pivotal decision marked a significant shift in Even’s strategy, moving from an aggregator model to becoming a direct provider of healthcare services. By building and operating its own hospitals, Even gains unprecedented control over the entire patient journey, from diagnostics and treatment protocols to doctor incentives and overall cost management. This vertical integration is crucial for implementing its value-based care model effectively and ensuring adherence to its stringent quality standards.
The transition to owning and operating hospitals began with the establishment of two facilities in Bengaluru. Remarkably, both hospitals achieved operational profitability, excluding depreciation, within a year of their opening. This rapid path to operational efficiency is a powerful testament to the viability of Even’s model and a key factor in attracting continued investor confidence. Buoyed by the success of these initial ventures and the fresh capital injection, Even plans to expand its footprint significantly, with five more hospitals slated to open in Bengaluru over the next six months. The company’s real estate strategy involves leasing hospital buildings on 20-year agreements and investing in fitting them out with state-of-the-art medical equipment, signaling a long-term commitment to infrastructure development.
A New Paradigm for Physician Compensation and Hospital Management
At the heart of Even’s value-based approach is a revolutionary compensation structure for its medical staff and hospital management. Unlike the prevalent system where doctors’ earnings are often tied to the number of tests ordered or surgeries performed, Even pays its doctors fixed salaries. This fundamental change eliminates the financial incentive for overtreatment, ensuring that clinical decisions are driven solely by patient needs. To further motivate excellence, doctors can earn bonuses based on patient-reported clinical outcomes, aligning their financial success directly with the health and satisfaction of their patients.
This principle of outcome-based incentives extends to hospital management as well. Managers’ compensation is delinked from the volume of procedures, instead comprising salaries and company-wide incentives. Even’s marketing teams, similarly, focus on attracting patients to the facilities rather than the revenue those patients might generate. This holistic approach ensures that every layer of the organization is geared towards patient well-being and operational efficiency, rather than maximizing billable services. Furthermore, in a move designed to foster a strong sense of ownership and long-term commitment, every employee, including doctors and other hospital staff, receives equity in Even. This strategy aims to align individual success with the startup’s overall performance and mission, reinforcing the focus on sustainable, high-quality care delivery.
Even’s revenue model is primarily driven by direct payments from patients for treatment. The startup also cultivates strategic relationships with insurers, exploring innovative models that could compensate it for hospitalizations it helps prevent, rather than merely for providing treatment. This proactive approach to health management and prevention, rather than reactive treatment, represents a significant shift in the payer-provider dynamic and holds the potential for substantial long-term savings for both patients and insurers.
Demonstrating Impact: Early Outcomes and Operational Efficiency
The efficacy of Even’s model is not just theoretical; it is backed by tangible results and transparent data. The startup meticulously tracks patient recovery post-treatment using established medical scoring systems. For instance, in the case of knee replacements, it employs the Oxford Knee Score to measure improvements in pain and mobility. These outcomes are not kept proprietary; Even publishes its results on its website, providing comparative data from other healthcare systems to offer context and demonstrate its performance against industry benchmarks. This commitment to transparency is a crucial element in building trust with patients and validating its disruptive model.
Even Healthcare proudly reports an unplanned readmission rate of less than 1% across its hospitals, a stark contrast to the industry benchmark which typically ranges from 8% to 15%. This significantly lower readmission rate is a powerful indicator of the quality of care provided and the effectiveness of its patient management protocols. Moreover, the company claims that its patients spend 40% less time in the hospital, suggesting more efficient treatment pathways and quicker recovery times. These efficiencies translate into substantial cost savings for insurers, with Even asserting that its approach has saved them more than ₹500 million (approximately $5.27 million). These compelling figures highlight the potential for Even’s model to not only improve patient outcomes but also to create a more economically sustainable healthcare system.
Jai Sajnani, a partner at Khosla Ventures, emphasized the critical role of these early performance indicators in the firm’s decision to lead the Series B round. "The clinical and economic results so far give us conviction that this can become an important new model for healthcare in India and beyond," stated Vinod Khosla, founder of Khosla Ventures, reiterating the firm’s belief in Even’s potential to transcend geographical boundaries. Sajnani added, "We look forward to helping the Even team put quality care within reach of every family in Bengaluru and across India," signaling the firm’s strategic commitment to Even’s expansion and impact.
Investor Confidence and Strategic Backing
Khosla Ventures’ consistent backing of Even Healthcare, from its seed round in 2021 to leading the latest Series B, underscores a deep conviction in the startup’s vision and execution. Vinod Khosla, a renowned Silicon Valley venture capitalist, is known for investing in disruptive technologies and business models that challenge established industries. His statement that Even’s approach "goes beyond fixing individual parts of a fragmented healthcare system by bringing financing, technology, and care delivery together" perfectly encapsulates the comprehensive nature of Even’s reform efforts. The goal, as Khosla articulated, is to "reward better health outcomes rather than greater use of healthcare services," a philosophy that aligns with the global shift towards value-based care.
The continued investment from a prominent firm like Khosla Ventures, alongside Alpha Wave, sends a strong signal to the broader investment community about the potential for innovation and disruption within the Indian healthcare sector. It validates the idea that a business model focused on ethical patient care and outcome-driven efficiency can be financially viable and scalable, even in a complex market like India. This sustained support is not merely financial; it brings strategic guidance and industry connections that are invaluable for a startup navigating the intricacies of healthcare delivery and regulatory frameworks.
Navigating Growth and Challenges: The Path Ahead
Despite its promising operational achievements and significant funding, Even Healthcare is currently operating at a net loss, a common trajectory for high-growth startups heavily investing in expansion. Regulatory filings show the startup posted a net loss of ₹902 million (approximately $9.50 million) in fiscal 2025, an increase of nearly 25% from the previous year, on a revenue of ₹272 million (about $2.86 million). This financial snapshot reflects the company’s strategic choice to prioritize aggressive growth and market penetration over immediate profitability.
Mayank Banerjee openly acknowledged this strategy, telling TechCrunch that while Even could achieve profitability within months by ceasing its expansion efforts, the company is deliberately choosing to invest in scaling its operations and serving more patients. "Right now, we’re investing in growth and serving more patients," Banerjee affirmed, declining to provide a specific timeline for achieving profitability. This approach is typical of venture-backed companies aiming to capture significant market share before consolidating their financial position.
In August, Even also underwent a significant restructuring, which involved laying off approximately 350 employees, according to Indian startup-news website Entrackr. Banerjee confirmed the difficult decision, stating that affected employees received severance, extended health insurance, and accelerated equity vesting. While such layoffs are challenging, they often represent a recalibration of resources and strategic realignment during periods of intense growth and operational refinement. Currently, Even employs about 650 people, including around 300 full-time doctors, indicating a substantial human capital base dedicated to its mission. Since its launch in 2021, the startup has served approximately 250,000 members and recorded over 750,000 patient interactions, encompassing consultations, diagnostic tests, and surgeries, demonstrating a rapidly expanding reach and impact.
Broader Implications for India’s Healthcare Ecosystem
Even Healthcare’s model holds profound implications for the broader Indian healthcare ecosystem. Should its success continue and scale, it could catalyze a significant shift towards value-based care across the country. Other private hospital chains and healthcare providers might be compelled to re-evaluate their own incentive structures and operational models to remain competitive and meet evolving patient expectations. This could lead to a more patient-centric, transparent, and ultimately more affordable healthcare system in India.
The emphasis on fixed salaries for doctors, combined with outcome-based bonuses and equity ownership, could also transform the professional landscape for medical practitioners. It offers a stable, ethical working environment where clinical decisions are unburdened by financial pressures, potentially attracting top talent disillusioned with the prevailing fee-for-service model.
Furthermore, Even’s collaborative approach with insurers, exploring models that reward prevention and efficient management, could foster deeper partnerships between payers and providers. This could lead to innovative insurance products that incentivize healthy lifestyles and proactive care, ultimately reducing the burden of chronic diseases and high-cost hospitalizations. The transparency in publishing clinical outcomes sets a new standard for accountability, potentially encouraging other institutions to follow suit and empowering patients with more informed choices.
The challenges, however, are considerable. Scaling such a capital-intensive model across a country as diverse and vast as India will require continuous innovation, significant capital, and adept navigation of local regulations and cultural nuances. Competition from established players, who may eventually adapt similar strategies, also looms. Nevertheless, Even Healthcare’s journey represents a bold, data-driven attempt to fundamentally reform a critical sector, promising a future where healthcare in India is not just accessible, but also ethical, efficient, and truly centered around the well-being of the patient. The success of this model could indeed serve as a blueprint, not just for India, but for other developing economies grappling with similar healthcare challenges.
